Peptide Therapeutics Market was valued at USD 47.2 Million in 2023, and is expected to reach USD 93.0 Million in 2033, at a CAGR of 7.2% NEW Y ...

Fintel reports that on February 3, 2025, HC Wainwright & Co. initiated coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...

H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Tenaya Therapeutics Inc (NASDAQ:TNYA), with a price target of $18.00. This aligns with the strong overall analyst consensus, as ...

Kroger Health, the healthcare division of The Kroger Co. and its Family of Pharmacies today announced a new agreement with Express Scripts, the pharmacy benefit services business of ...

Clinical Trial of TN-401 Gene Therapy for the Potential Treatment of PKP2-Associated Arrhythmogenic Right Ventricular ...

Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics ... today announced that the California Institute for Regenerative Medicine (CIRM), a state of California Agency that funds regenerative ...

Tenaya Therapeutics (TNYA) announced that the California Institute for Regenerative Medicine, CIRM,, a state of California Agency that funds regenerative medicine, stem cell, and gene therapy ...

Funding will Support Ongoing RIDGE™-1 Clinical Trial of TN-401 Gene Therapy for the Potential Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy Initial Data from RIDGE-1 ...

United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...

Ana Moreno, PhD, Chief Executive Officer, Navega Therapeutics ... California Institute for Regenerative Medicine (CIRM) The California Institute for Regenerative Medicine's mission is accelerating ...